Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02643797 · ClinicalTrials.gov registry record · Phase 3
Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings
A Phase 3 study, sponsored by Scripps Whittier Diabetes Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 602
- Enrollment target
NCT02643797: Completed Phase 3 study, sponsored by Scripps Whittier Diabetes Institute.
NCT02643797 is a Phase 3 study that has completed, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 602 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (22% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02643797, a Phase 3 study, has completed, sponsored by Scripps Whittier Diabetes Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 602 participants
- Enrollment target
Study Summary
This study is a cluster (clinic level) randomized pragmatic trial to compare the effectiveness of MA Health Coaching (MAC) delivered by non-clinician primary care staff (i.e., MAs) versus usual care (UC) in improving diabetes clinical control among individuals with poorly controlled type 2 diabetes mellitus (T2DM).
Interventions
- BEHAVIORAL Medical Assistant Health Coaching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2016-03-07 |
| Est. Completion | 2020-04-19 |
| Phase | Phase 3 |
What the finished NCT02643797 record still lists
NCT02643797 is an interventional study that assigns participants to a tested intervention. The registered 602 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (22% lower).
The record links to 0 conditions, and to 1 intervention - of which Medical Assistant Health Coaching is the first listed.
NCT02643797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02643797 about?
NCT02643797 is a clinical study titled "Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings". This study is a cluster (clinic level) randomized pragmatic trial to compare the effectiveness of MA Health Coaching (MAC) delivered by non-clinician primary care staff (i.e., MAs) versus usual care (UC) in improving diabetes clinical control among individuals with poorly controlled type 2 diabetes ...
What is the current status of trial NCT02643797?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 602 participants. The study started on 2016-03-07. Estimated completion is 2020-04-19.
What interventions are being tested in trial NCT02643797?
The interventions under investigation include: Medical Assistant Health Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT02643797?
This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02643797's enrollment target sits among peer trials
602 607th of 2000 higher than 1,393 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI